| Symbol | DMRA |
|---|---|
| Name | DAMORA THERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 221 CRESCENT STREET, WALTHAM, MA 02453 |
| Telephone | (781) 281-9020 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001800315 |
| Description | None |
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more(99% Neutral) DAMORA THERAPEUTICS, INC. (DMRA) Provides Update on care for people w
Read moreWinslow Garrett 🟡 adjusted position in 245 shares (1 derivative) of Damora Therapeutics, Inc. (DMRA) at $29.98 Transaction Date: Jul 03, 2026 | Filing ID: 297818
Read moreDamora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read more📋 Firmani Lori (Officer) plans to sell 8K shares of Damora Therapeutics, Inc. (at $25.36 each, total $193K) Filed: Jun 22, 2026 | ID: 000017
Read more(99% Neutral) DAMORA THERAPEUTICS, INC. (DMRA) Announces Regulatory Update
Read moreNew Form SCHEDULE 13G/A - Damora Therapeutics, Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000919574-26-003477 <b>Size:</b> 12 KB
Read moreNew Form SCHEDULE 13G/A - Damora Therapeutics, Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000902664-26-002524 <b>Size:</b> 11 KB
Read moreNew Form SCHEDULE 13G - Damora Therapeutics, Inc. <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0000902664-26-002463 <b>Size:</b> 14 KB
Read more